369 related articles for article (PubMed ID: 12891943)
1. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients].
Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM
Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
3. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P
N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847
[TBL] [Abstract][Full Text] [Related]
4. Pure red-cell aplasia and epoetin therapy.
Bennett CL; Luminari S; Nissenson AR; Tallman MS; Klinge SA; McWilliams N; McKoy JM; Kim B; Lyons EA; Trifilio SM; Raisch DW; Evens AM; Kuzel TM; Schumock GT; Belknap SM; Locatelli F; Rossert J; Casadevall N
N Engl J Med; 2004 Sep; 351(14):1403-8. PubMed ID: 15459301
[TBL] [Abstract][Full Text] [Related]
5. [Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia].
Stenvinkel P; Bárány P
Lakartidningen; 2002 Oct; 99(42):4162-3. PubMed ID: 12448296
[No Abstract] [Full Text] [Related]
6. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
[TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another.
Macdougall IC
Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076
[TBL] [Abstract][Full Text] [Related]
8. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
Fraer M; Campbell A; Sawaya BP
Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced autoimmune red-cell aplasia.
Bunn HF
N Engl J Med; 2002 Feb; 346(7):522-3. PubMed ID: 11844855
[No Abstract] [Full Text] [Related]
10. [Pure red cell aplasia developed during treatment with erythropoietin. Complete remission during immunosuppressive therapy].
Høi-Hansen T; Lauritzen AM; Hansen PB
Ugeskr Laeger; 2003 May; 165(19):2001-2. PubMed ID: 12795077
[TBL] [Abstract][Full Text] [Related]
11. Pure red-cell aplasia secondary to antierythropoietin antibodies.
Guest SS; Levitt L
N Engl J Med; 2003 Dec; 349(26):2572-3. PubMed ID: 14695426
[No Abstract] [Full Text] [Related]
12. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
13. Epoetin-induced pure red cell aplasia: diagnosis and treatment.
Macdougall IC
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):585-8. PubMed ID: 18089975
[TBL] [Abstract][Full Text] [Related]
14. Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation.
Vartia A; Asola MR; Tertti R; Kunelius P; Metsärinne KP
Nephrol Dial Transplant; 2004 May; 19(5):1313-6. PubMed ID: 15102972
[No Abstract] [Full Text] [Related]
15. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
[TBL] [Abstract][Full Text] [Related]
16. [Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].
Grzegorzewska AE; Sucharzewska-Tomczak M
Pol Merkur Lekarski; 2004 Oct; 17(100):407-9. PubMed ID: 15690716
[TBL] [Abstract][Full Text] [Related]
17. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?
Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM
Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566
[No Abstract] [Full Text] [Related]
18. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
Rossert J;
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
[TBL] [Abstract][Full Text] [Related]
19. Eprex-associated pure red cell aplasia and leachates.
Schellekens H; Jiskoot W
Nat Biotechnol; 2006 Jun; 24(6):613-4. PubMed ID: 16763579
[No Abstract] [Full Text] [Related]
20. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):481-9. PubMed ID: 15792923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
